Evidence method
Level · gp.fundamentals.debt_to_revenue
195.39% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
PHAT · Sep 30, 2026
Phathom Pharmaceuticals, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001193125-26-436961General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.13% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
2.17% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
71.14% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
9.01% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
78.32% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-0.10% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
10.32% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
6.99% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History4 statesHistory building
Period transition
What moved in the state?
- Previous
- 221.59%
- Current
- 195.39%
- Delta
- -26.20%
- Previous
- 0.06%
- Current
- 0.13%
- Delta
- 0.07%
- Previous
- -2.60%
- Current
- 2.17%
- Delta
- 4.77%
- Previous
- 88.02%
- Current
- 71.14%
- Delta
- -16.88%
- Previous
- 10.38%
- Current
- 9.01%
- Delta
- -1.38%
- Previous
- 79.68%
- Current
- 78.32%
- Delta
- -1.35%
- Previous
- -5.34%
- Current
- -0.10%
- Delta
- 5.24%
- Previous
- 10.52%
- Current
- 10.32%
- Delta
- -0.20%
- Previous
- 9.04%
- Current
- 6.99%
- Delta
- -2.05%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Pharmaceutical Preparations peers →Derived From · PHAT Company Quality Vector →Has State · Phathom Pharmaceuticals, Inc. →Transitioned To · PHAT BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · PHAT CAPEX_INTENSITY_INCREASED →Transitioned To · PHAT CASH_GENERATION_INCREASED →Transitioned To · PHAT GROWTH_DECREASED →Transitioned To · PHAT INVENTORY_PRESSURE_DECREASED →Transitioned To · PHAT MARGIN_DECREASED →Transitioned To · PHAT PROFITABILITY_INCREASED →Transitioned To · PHAT R_AND_D_INTENSITY_DECREASED →Transitioned To · PHAT SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.